(Q44881213)

English

The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic le

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic le (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Tao Fu

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Debnath Mukhopadhyay

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Nicholas O Davidson

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Jayme Borensztajn

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

27 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

279

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

28662-28669

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Identification and regulation of protein components of the apolipoprotein B mRNA editing enzyme. A complex event

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Receptor and non-receptor mediated uptake of chylomicron remnants by the liver

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

The emergence of mouse models of atherosclerosis and their relevance to clinical research

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

The role of fibric acids in atherosclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Overexpression of SR-BI by adenoviral vector reverses the fibrateinduced hypercholesterolemia of apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic Acid editing in a murine model of congenital hypothyroidism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

The inhibition in vivo of lipoprotein lipase (clearing-factor lipase) activity by triton WR-1339

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Perfluorooctanoic acid, a peroxisome-proliferating hypolipidemic agent, dissociates apolipoprotein B48 from lipoprotein particles and decreases secretion of very low density lipoproteins by cultured rat hepatocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Re-emergence of fibrates in the management of dyslipidemia and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

The peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein E

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403271200

21 January 2018

Identifiers

10.1074/JBC.M403271200

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44881213&oldid=1239277949"